{
    "RADCURE-0769": {
        "question": "Age: 71.8, Sex: Female, ECOG PS: ECOG 1, Smoking PY: na, Smoking Status: unknown, Ds Site: Oropharynx, Subsite: Tonsil, T: T2, N: N0, M : M0, Stage: II, Path: Squamous Cell Carcinoma, HPV: Negative, Tx Modality: RT alone, Chemo? : none, Dose: 70.0, Fx: 35, Local: none, Regional: none, Distant: none, 2nd Ca: Y, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-negative cases. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the cervical spine, oropharyngeal airway, base of tongue, and soft tissues of the neck.\n- The airway appears patent without obvious obstruction.\n- The vertebral bodies and intervertebral discs are visible and appear intact without gross deformity.\n- The masked region of interest (ROI) is located in the oropharyngeal region, specifically around the base of tongue and possibly extending to the tonsillar area.\n- The ROI is highlighted in purple, suggesting it corresponds to a pathological lesion or target volume for radiation therapy.\n- No obvious large lymphadenopathy or distant metastases are visible in this single slice.\n- Soft tissue swelling or mass effect is noted in the oropharyngeal region corresponding to the ROI.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates are given as:\n\n- Box 1: [272, 136, 93, 272, 183, 110]\n- Box 2: [257, 194, 104, 257, 224, 131]\n\nThese coordinates correspond to volumetric regions within the scan, normalized to image size.\n\n- Box 1 appears to be localized in the oropharyngeal region, likely encompassing the primary tumor site (base of tongue or tonsillar region).\n- Box 2 is located slightly inferior and posterior, possibly corresponding to regional lymph nodes or adjacent soft tissue structures.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 71.8-year-old female with oropharyngeal squamous cell carcinoma located in the tonsil.\n- Tumor staging is T2N0M0, stage II, indicating a moderately sized primary tumor without nodal or distant metastases.\n- HPV status is negative, which is associated with a less favorable prognosis compared to HPV-positive tumors.\n- ECOG performance status is 1, indicating slight symptoms but generally ambulatory.\n- Treatment is radiation therapy alone, 70 Gy in 35 fractions, without chemotherapy.\n- No local, regional, or distant recurrence noted at the time of imaging.\n- Presence of a second cancer is noted, which may impact overall prognosis.\n- The masked ROI corresponds to the primary tumor site targeted for radiation.\n- Bounding boxes likely delineate the tumor and possibly involved lymph nodes or at-risk regions.\n- Given the absence of nodal disease and the use of definitive radiation therapy, the prognosis is cautiously optimistic but tempered by HPV negativity and second cancer presence.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a localized oropharyngeal tumor in the tonsillar region without evident nodal involvement.\n- The masked ROI and bounding boxes correspond to the primary tumor and possibly adjacent at-risk tissues.\n- Clinical staging and imaging suggest a stage II HPV-negative oropharyngeal squamous cell carcinoma treated with definitive radiation therapy.\n- The patient's performance status and treatment modality are appropriate for this stage.\n- The presence of a second cancer and HPV negativity may reduce overall survival probability.\n- Overall, the patient has a moderate prognosis with a reasonable chance of survival given the localized disease and treatment.\n\nAnswer: Alive",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate-radiation oncologist": "No",
        "Round 2-Turn 1-ask_gap-radiation oncologist": "Yes. A medical oncologist or head and neck surgical oncologist would be beneficial to provide input on systemic therapy options and surgical considerations, especially given the presence of a second cancer and HPV-negative status, which may influence overall treatment strategy beyond radiation planning. Additionally, a radiologist specialized in head and neck imaging could assist with detailed interpretation of imaging findings and staging confirmation.",
        "Round 2-Turn 1-gap_identified-assistant": "- Consult a medical oncologist for input on systemic therapy options given the presence of a second cancer and HPV-negative status.  \n- Consult a head and neck surgical oncologist for surgical considerations in the context of the second cancer and HPV-negative status.  \n- Consult a radiologist specialized in head and neck imaging for detailed interpretation of imaging findings and staging confirmation.",
        "Round 2-Turn 1-gap_recruit-recruiter": "1. Medical Oncologist - Your expertise is strictly limited to systemic therapy decisions, including chemotherapy and immunotherapy in head and neck cancers, with consideration of second primary cancers and HPV-negative status. - Hierarchy: Medical Oncologist == Radiation Oncologist  \n2. Surgical Oncologist (Recurrence/Secondary Cancers) - Your expertise is strictly limited to evaluating surgical options for recurrent or secondary malignancies in head and neck cancers, especially in HPV-negative patients. - Hierarchy: Surgical Oncologist == Radiation Oncologist  \n3. Radiologist (Head and Neck Imaging Specialist) - Your expertise is strictly limited to detailed interpretation of head and neck imaging, staging confirmation, and assessment of second primary cancers. - Hierarchy: Radiologist == Radiation Oncologist",
        "Round 2-Turn 1-gap_recruited_assessment-medical oncologist": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the cervical vertebrae, oropharyngeal airway, base of tongue, and soft tissues of the neck.\n- The airway appears patent without obvious obstruction.\n- The vertebral bodies and intervertebral discs appear intact without gross deformity or fracture.\n- The masked region of interest (ROI) is located in the oropharyngeal region, specifically around the base of tongue and possibly extending to the tonsillar area.\n- The ROI is highlighted in purple, suggesting it corresponds to a pathological lesion or target volume for radiation therapy.\n- No obvious large lymphadenopathy or distant metastases are visible in this single sagittal slice.\n- There is no evident soft tissue swelling or mass effect outside the ROI.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates:\n\n- Box 1: [272, 136, 93, 272, 183, 110]\n- Box 2: [257, 194, 104, 257, 224, 131]\n\nThese coordinates correspond to volumetric regions within the scan, normalized to image size.\n\n- Box 1 is localized in the oropharyngeal region, likely encompassing the primary tumor site at the base of tongue or tonsillar area.\n- Box 2 is located slightly inferior and posterior, possibly corresponding to regional lymph nodes or adjacent soft tissue structures in the neck.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 71.8-year-old female diagnosed with oropharyngeal squamous cell carcinoma located in the tonsil.\n- Tumor staging is T2N0M0, stage II, indicating a moderately sized primary tumor without nodal or distant metastases.\n- HPV status is negative, which is associated with a less favorable prognosis compared to HPV-positive tumors.\n- ECOG performance status is 1, indicating slight symptoms but generally ambulatory.\n- Treatment consists of radiation therapy alone, 70 Gy in 35 fractions, without chemotherapy.\n- No local, regional, or distant recurrence is noted at the time of imaging.\n- Presence of a second primary cancer is noted, which may impact overall prognosis.\n- The masked ROI corresponds to the primary tumor site targeted for radiation.\n- Bounding boxes likely delineate the tumor and possibly involved lymph nodes or at-risk regions.\n- Given the absence of nodal disease and the use of definitive radiation therapy, the prognosis is cautiously optimistic but tempered by HPV negativity and second cancer presence.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a localized oropharyngeal tumor in the tonsillar region without evident nodal involvement.\n- The masked ROI and bounding boxes correspond to the primary tumor and possibly adjacent at-risk tissues.\n- Clinical staging and imaging suggest a stage II HPV-negative oropharyngeal squamous cell carcinoma treated with definitive radiation therapy.\n- The patient's performance status and treatment modality are appropriate for this stage.\n- The presence of a second cancer and HPV negativity may reduce overall survival probability.\n- Overall, the patient has a moderate prognosis with a reasonable chance of survival given the localized disease and treatment.\n\nAnswer: Alive",
        "Round 2-Turn 1-gap_recruited_assessment-surgical oncologist (recurrence/secondary cancers)": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the cervical vertebrae, oropharyngeal airway, base of tongue, and soft tissues of the neck.\n- The airway appears patent without significant obstruction.\n- The vertebral bodies and intervertebral discs appear intact without gross deformity.\n- The masked region of interest (ROI) is located in the oropharyngeal region, specifically around the base of tongue and tonsillar area.\n- The ROI is highlighted in purple, indicating a pathological lesion or target volume, likely the primary tumor.\n- No obvious large lymphadenopathy or distant metastases are visible in this slice.\n- There is some soft tissue swelling or mass effect in the oropharyngeal region corresponding to the ROI.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates:\n\n- Box 1: [272, 136, 93, 272, 183, 110]\n- Box 2: [257, 194, 104, 257, 224, 131]\n\nThese coordinates correspond to volumetric regions within the scan.\n\n- Box 1 is localized in the oropharyngeal region, likely encompassing the primary tumor site in the tonsillar or base of tongue area.\n- Box 2 is located slightly inferior and posterior, possibly corresponding to regional lymph nodes or adjacent soft tissue structures.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 71.8-year-old female with oropharyngeal squamous cell carcinoma located in the tonsil.\n- Tumor staging is T2N0M0, stage II, indicating a moderately sized primary tumor without nodal or distant metastases.\n- HPV status is negative, which is associated with a less favorable prognosis compared to HPV-positive tumors.\n- ECOG performance status is 1, indicating slight symptoms but generally ambulatory.\n- Treatment is radiation therapy alone, 70 Gy in 35 fractions, without chemotherapy.\n- No local, regional, or distant recurrence noted at the time of imaging.\n- Presence of a second cancer is noted, which may impact overall prognosis.\n- The masked ROI corresponds to the primary tumor site targeted for radiation.\n- Bounding boxes likely delineate the tumor and possibly involved lymph nodes or at-risk regions.\n- Given the absence of nodal disease and the use of definitive radiation therapy, the prognosis is cautiously optimistic but tempered by HPV negativity and second cancer presence.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a localized oropharyngeal tumor in the tonsillar region without evident nodal involvement.\n- The masked ROI and bounding boxes correspond to the primary tumor and possibly adjacent at-risk tissues.\n- Clinical staging and imaging suggest a stage II HPV-negative oropharyngeal squamous cell carcinoma treated with definitive radiation therapy.\n- The patient's performance status and treatment modality are appropriate for this stage.\n- The presence of a second cancer and HPV negativity may reduce overall survival probability.\n- Overall, the patient has a moderate prognosis with a reasonable chance of survival given the localized disease and treatment.\n\nAnswer:  \nAlive",
        "Round 2-Turn 1-gap_recruited_assessment-radiologist (head and neck imaging specialist)": "**Step 1: Initial Assessment of the CT Scan (without bounding box data)**\n\n- The image is a sagittal CT scan of the head and neck region with contrast enhancement.\n- Visible anatomical structures include the cervical vertebrae, oropharyngeal airway, base of tongue, and soft tissues of the neck.\n- The airway appears patent without significant obstruction.\n- The vertebral bodies and intervertebral discs are intact without obvious deformity or fracture.\n- The masked region of interest (ROI) is located in the oropharyngeal region, specifically around the base of tongue and tonsillar area.\n- The ROI is highlighted in purple, suggesting it corresponds to a pathological lesion, likely the primary tumor.\n- There is no obvious large lymphadenopathy or gross soft tissue mass outside the ROI in this single sagittal slice.\n- No signs of distant metastases or gross invasion into adjacent bony structures are visible.\n\n**Step 2: Mapping Bounding Boxes**\n\nBounding box coordinates:\n\n- Box 1: [272, 136, 93, 272, 183, 110]\n- Box 2: [257, 194, 104, 257, 224, 131]\n\nThese coordinates correspond to volumetric regions within the scan.\n\n- Box 1 is localized in the oropharyngeal region, likely encompassing the primary tumor site in the tonsillar or base of tongue area.\n- Box 2 is located inferior and posterior to Box 1, possibly corresponding to regional lymph nodes or adjacent soft tissue structures in the neck.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 71.8-year-old female with oropharyngeal squamous cell carcinoma located in the tonsil.\n- Tumor staging is T2N0M0, stage II, indicating a moderately sized primary tumor without nodal or distant metastases.\n- HPV status is negative, which is associated with a less favorable prognosis compared to HPV-positive tumors.\n- ECOG performance status is 1, indicating slight symptoms but generally ambulatory.\n- Treatment is radiation therapy alone, 70 Gy in 35 fractions, without chemotherapy.\n- No local, regional, or distant recurrence noted at the time of imaging.\n- Presence of a second cancer is noted, which may impact overall prognosis.\n- The masked ROI corresponds to the primary tumor site targeted for radiation.\n- Bounding boxes likely delineate the tumor and possibly involved lymph nodes or at-risk regions.\n- Given the absence of nodal disease and the use of definitive radiation therapy, the prognosis is cautiously optimistic but tempered by HPV negativity and second cancer presence.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a localized oropharyngeal tumor in the tonsillar region without evident nodal involvement.\n- The masked ROI and bounding boxes correspond to the primary tumor and possibly adjacent at-risk tissues.\n- Clinical staging and imaging suggest a stage II HPV-negative oropharyngeal squamous cell carcinoma treated with definitive radiation therapy.\n- The patient's performance status and treatment modality are appropriate for this stage.\n- The presence of a second cancer and HPV negativity may reduce overall survival probability.\n- Overall, the patient has a moderate prognosis with a reasonable chance of survival given the localized disease and treatment.\n\nAnswer: Alive",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-medical oncologist": "No",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-surgical oncologist (recurrence/secondary cancers)": "No",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-radiologist (head and neck imaging specialist)": "No",
        "Round 2-role-comment": "radiation oncologist:alive|medical oncologist:alive|surgical oncologist (recurrence/secondary cancers):alive|radiologist (head and neck imaging specialist):alive",
        "Round 2-num_agents": 4,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Alive',)"
    }
}